OPKO Health, Inc. Accounts Payable
OPKO Health, Inc. (OPK) had Accounts Payable of $50.04 million as of 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-28
- 2026-06-30: Accounts Payable, Current $50.04M.
- 2026-03-31: Accounts Payable, Current $44.18M.
- 2025-12-31: Accounts Payable, Current $41.10M.
- 2025-09-30: Accounts Payable, Current $50.83M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $50.04M 10-Q/A · filed 2026-08-28 | |
| 2026-03-31 | $44.18M 10-Q/A · filed 2026-08-28 | |
| 2025-12-31 | $41.10M 10-Q/A · filed 2026-08-28 | |
| 2025-09-30 | $50.83M 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $56.68M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $59.37M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $47.07M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $62.72M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $82.24M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $71.16M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $69.68M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $66.80M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $87.88M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $80.50M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $66.99M 10-K · filed 2024-03-01 | |
| 2022-09-30 | $49.75M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $56.11M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $94.24M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $82.04M 10-K · filed 2023-02-27 | |
| 2021-09-30 | $94.39M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $88.51M 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $162.69M 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $100.88M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $65.69M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $44.67M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $55.87M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $62.54M 10-K · filed 2021-02-18 | |
| 2019-09-30 | $77.30M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $60.38M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $51.09M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $47.40M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $65.61M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $69.06M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $64.23M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $74.31M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $66.54M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $62.15M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $74.56M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $53.36M 8-K · filed 2019-01-29 | |
| 2016-09-30 | $58.54M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $61.06M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $73.44M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $72.53M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $77.97M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $16.04M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $10.47M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $8.74M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $8.84M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $10.04M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $14.70M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $13.41M 10-K · filed 2015-02-27 | |
| 2013-09-30 | $13.63M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $11.65M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $11.29M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $10.20M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $7.24M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $4.40M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $4.88M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $4.89M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $2.56M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $2.89M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $6.48M 10-K · filed 2012-03-15 | $7.17M 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |